B
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Price:
6.52
CNY
1.09%
Market Closed
Market Cap:
¥6.7B
Relative Value
The Relative Value of one Beijing SL Pharmaceutical Co Ltd stock under the Base Case scenario is 5 CNY. Compared to the current market price of 6.52 CNY, Beijing SL Pharmaceutical Co Ltd is Overvalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
5
CNY
Overvaluation 23%
B
Multiples Across Competitors
Competitors Multiples
Beijing SL Pharmaceutical Co Ltd Competitors
Beijing SL Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
|
6.7B CNY | 11.6 | 80 | -401.1 | -401.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.4B USD | 6.6 | 168.3 | 16.3 | 23.1 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.6B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178.7B USD | 6 | 20.9 | 14.2 | 14.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.2B USD | 10.1 | 30.7 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.7B AUD | 3.2 | 16.6 | 11.4 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
40.3B EUR | 13.2 | 31.1 | 52.8 | 54.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
